Michael U Callaghan (M U Callaghan)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 9

Top Topics

Locally Advanced

Atrial Fibrillation

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Christine L Kempton, Peter Trask, Aric Parnes, Markus Niggli, Avrita Campinha-Bacote, Michael U Callaghan, Niamh O'Connell, Ido Paz-Priel, Johnny N Mahlangu
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Serina B Beydoun, Yogindra Persaud, Jennifer Lafferty, Michael U Callaghan, Süreyya Savasan
Bortezomib treatment of steroid-refractory Evans syndrome in children. Pediatric blood & cancer 67 (12) (2020)
Lynn M Malec, Stacy E Croteau, Michael U Callaghan, Robert F Sidonio
Spontaneous bleeding and poor bleeding response with extended half-life factor IX products: A survey of select US haemophilia treatment centres. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Ahmar U Zaidi, Latha Rao, Michael U Callaghan, Madhvi Rajpurkar, Wendy Hollon, Meera B Chitlur
Concurrent homozygous sickle-cell disease and severe haemophilia A: Thromboelastography profiles. Haemophilia : the official journal of the World Federation of Hemophilia 25 (2) (2019)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Maria Elisa Mancuso, Peter Trask, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres, Sylvia von Mackensen
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS). Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Michael U Callaghan, Robert F Sidonio, Steven W Pipe
Novel therapeutics for hemophilia and other bleeding disorders. Blood 132 (1) (2018)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Elena Santagostino, Maggie Moore, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi-centre, non-interventional study. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Johannes Oldenburg, Johnny N Mahlangu, Willem Bujan, Peter Trask, Michael U Callaghan, Guy Aaron Young, Elina Asikanius, Flora Peyvandi, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler, Jin Xu, Jerzy Windyga, Midori Shima, Sylvia von Mackensen
The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)
Michael U Callaghan
Identifying bleeding: Go with the flow. Haemophilia : the official journal of the World Federation of Hemophilia 23 (5) (2017)